BioMarin Pharmaceutical | BMRN - 贸易债权人

金融业

USD

USD 8.59B

现金及等价物

USD 2.22B

USD 199.48M

USD 4.61B

USD 793.15M

USD 1.44B

USD 129.65M

USD 146.05M

3.04K

EPS每股收益

USD 0.76

股本和储备

USD 6.21B

USD 571.21M

债务利息支出

USD 14.96M

USD 22.56M

USD 1.43B

USD 10.66B

USD 105.53M

USD 636.56M

USD 129.65M

普通股股本

USD 193.27M

15.28

USD 141.2M

USD 766M

销售和管理费用

USD 258.28M

USD 1.27B

贸易债权人

USD 793.15M

应收帐款人

USD 903.91M

	贸易债权人	更改		日
Acadia Pharmaceuticals	USD 12.25M		1.34M	2026-03
Agios Pharmaceuticals	USD 13.75M		4.61M	2026-03
Alnylam Pharmaceuticals	USD 126.63M		10.91M	2026-03
Amgen	USD 19.52B		1.37B	2026-03
Bayer	EUR 6.59B		496M	2026-03
Biogen	USD 358.5M		73.5M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Gilead Sciences	USD 645M		70M	2026-03
Incyte	USD 228.62M		1.41B	2026-03
Insmed	USD 73.38M		6.53M	2026-03
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
Moderna	USD 161M		156M	2026-03
Neurocrine Biosciences	USD 691.3M		145.8M	2026-03
PTC Therapeutics	USD 25.48M		20M	2026-03
Puma Biotechnology	USD 6.39M		962K	2025-09
Regeneron Pharmaceuticals	USD 1.03B		4.81B	2026-03
Roche Holding	CHF 5.78B		1.27B	2025-12
Sangamo BioSciences	USD 10.74M		7.46M	2025-06
Sanofi	EUR 22.93B		2.89B	2025-12
Sarepta Therapeutics	USD 70.38M		210.46M	2026-03
Ultragenyx Pharmaceutical	USD 42M		11M	2026-03
United Therapeutics	USD 498.3M		491.2M	2026-03
Vertex Pharmaceuticals	USD 3.47B		40.6M	2026-03